BioSpace News Archive

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced it will present data from multiple studies of RINVOQ™ (upadacitinib), HUMIRA® (adalimumab) and SKYRIZI™ (risankizumab) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, November 8-13, in Atlanta.

Teprotumumab is an investigational medicine and its safety and efficacy have not been established.

Chemical oxygen generators are devices used to produce pure, breathable oxygen for use in enclosed spaces, including submarines.

Leslie E. Harmon, BSN, RN is honored to be named a Board Director.

There is also a growing emphasis on performance-based compensation for senior leaders to tie rewards to attaining short-term and long-term goals.

SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Pharmaceutical Formulation Market - Procurement Intelligence Report.

Acasti Pharma Inc. announced that it has partnered with Aker BioMarine to deliver krill oil to Acasti, under a two-year, fixed price supply agreement.

Mezzion Pharma Co. Ltd. announces that on Sunday, November 17, 2019, at 10:45 am EST, Dr. David Goldberg, Children’s Hospital of Philadelphia, will present the results of Mezzion’s landmark FUEL Phase 3 Clinical Trial.

GI Alliance, the nation’s leading physician-led GI services organization, announced its partnership with Indianapolis Gastroenterology and Hepatology IGH is the largest private group of gastroenterologists in Indiana with 16 physicians and 10 advanced practice providers, caring for patients in 8 locations throughout the state.

Blue Cross and Blue Shield of Oklahoma announced a multi-state education and outreach campaign aimed at decreasing the number of uninsured and underinsured Americans.